Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-23-057725

Chief Executive Officer sold 19,050 shares at an average $2.29 ($43,684)

  • Chief Executive Officer acquired 70,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Marlan D · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-05 Exercise or conversion : show line 1 in the form +70,000 81,615 D
2023-12-06 Sale : show line 2 in the form −14,500 $2.31 $33,496 67,115 D
2023-12-07 Sale : show line 3 in the form −4,550 $2.24 $10,187 62,565 D
Open-market sales · 19,050 sh · avg $2.29 · $43,684

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-05 Exercise or conversion : show line 4 in the form Restricted Stock Units −70,000 0 D
Loading xslF345X05/doc4.xml…